AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threatnews2025-07-22T18:26:45+00:00July 22nd, 2025|The New York Times|
Trump Administration’s N.I.H. and F.D.A. Cuts Could Curtail New Drug Development, Budget Office Saysnews2025-07-18T16:08:45+00:00July 18th, 2025|The New York Times|
U.S.A.I.D. Might Be Dead, but the Waste Is Alive and Wellnews2025-07-02T09:02:22+00:00July 2nd, 2025|The New York Times|
Trump Claims There’s Waste and Abuse in U.S.A.I.D. Here It Is.news2025-06-21T10:50:00+00:00June 21st, 2025|The New York Times|
F.D.A. to Use A.I. in Drug Approvals to ‘Radically Increase Efficiency’news2025-06-10T18:30:10+00:00June 10th, 2025|The New York Times|
Kennedy Says ‘Charlatans’ Are No Reason to Block Unproven Stem Cell Treatmentsnews2025-06-05T16:07:54+00:00June 5th, 2025|The New York Times|
Who is Calley Means, Kennedy’s Health Adviser?news2025-05-22T09:03:22+00:00May 22nd, 2025|The New York Times|
In the Future, China Will Be Dominant. The U.S. Will Be Irrelevant.news2025-05-19T06:19:57+00:00May 19th, 2025|The New York Times|
Trump Signs Executive Order Asking Companies to Lower Drug Pricesnews2025-05-12T19:14:13+00:00May 12th, 2025|The New York Times|
Trump Signs Executive Order Asking Drugmakers to Slash Pricesnews2025-05-12T17:40:02+00:00May 12th, 2025|The New York Times|
